Hero Brain Health is committed to delivering evidence-based treatment and being transparent about our outcomes. We don’t just promise results – we measure them, document them, and hold ourselves accountable to the highest standards of care. Below you’ll find data from clinical research and statewide pilot programs that underscore the effectiveness of our eTMS approach. We’re proud to share this evidence because we want you, as well as medical professionals and policymakers, to have confidence in the impact of our program.

FDA Clearance for PTSD (2026)

On June 3, 2026, the U.S. Food and Drug Administration cleared Wave Neuroscience's MeRT System, the EEG-guided TMS technology used in our program, as an adjunct treatment for adults with post-traumatic stress disorder (510(k) K260402). The clearance was supported by a double-blind, sham-controlled clinical trial of 158 adults conducted with Texas A&M University. Standard TMS has been FDA-cleared for major depressive disorder since 2008.

Clinical Proof - Early Study (2015)

In one of the first studies of EEG-guided magnetic stimulation for PTSD, 16 combat veterans saw their PTSD severity scores drop by an average of 42% in just two weeks of treatment. Specifically, their Post-Traumatic Stress Disorder Checklist (PCL) scores went from ~55 before treatment to ~32 after treatment (a clinically significant improvement). Every single patient in that trial improved to some degree, and the researchers noted concurrent changes in brainwave patterns towards normal ranges – objective evidence that the brain was healing. This pioneering study, led by neuroscientist Alexander Taghva in 2015, helped lay the groundwork for our therapy, showing that personalized magnetic stimulation can achieve substantial relief for PTSD when conventional therapies fall short.

Ohio Pilot Program Data

The state of Ohio was one of the first to deploy eTMS on a large scale for its veterans and first responders, and the results have been closely tracked. To date, over 800 individuals have received eTMS treatment through the Ohio pilot, which began in 2021. According to 2025 testimony presented to the Ohio legislature, those patients experienced significant improvements in sleep quality and marked reductions in PTSD and depression symptoms on objective scales. In fact, Ohio set up a real-time data dashboard (run by the Department of Mental Health & Addiction Services) to collect outcomes – and as of early 2025, over 4,000 clinical data points have been gathered, showing consistent symptom reduction across the board. This transparency is a model for how we at Hero Brain Health plan to operate as well. We continually gather outcome metrics (like PCL-5 for PTSD, PHQ-9 for depression, GAD-7 for anxiety, etc.) to ensure our treatments are effective. The Ohio program’s success also led the state legislature to move from a pilot to a fully funded ongoing program – a testament to the confidence gained from the data. We are proud to base our Massachusetts program on the same evidence-backed protocols used in Ohio.

Florida & Missouri – Scalable Success

States like Florida and Missouri have launched similar initiatives with equally promising results, demonstrating that this model is scalable and repeatable. In Florida, a network of eTMS clinics has been established statewide (in Miami, Orlando, Tampa, Jacksonville, etc.), and they have provided free treatment to about 1,000 veterans and first responders. In June 2026, Florida extended its eTMS program for veterans and first responders through July 2027. Media reports and patient testimonials from these clinics frequently highlight dramatic improvements – from better sleep to reduced anxiety – that have given people their lives back. Missouri’s program, which opened its first clinics in 2023 with state funding, reported early on that 85–90% of treated individuals showed measurable improvement, with overall symptom severity decreasing by roughly 55–70% on average (KCTV5, 2023). By January 2026, the program had treated more than 1,000 people and opened a new clinic in Gladstone. Such real-world data not only validate our approach but also inspire confidence that Hero Brain Health can achieve similar outcomes for our New England patient community.

Continuous Improvement

We believe that what gets measured gets improved. Hero Brain Health has implemented rigorous outcome monitoring from day one. When you enroll in our program, we will seek your consent to track your progress with validated questionnaires at baseline, mid-treatment, and post-treatment, as well as optional follow-ups at intervals after treatment. By aggregating this anonymous data, we aim to contribute to the growing body of evidence supporting eTMS. We share de-identified results with our partners and funders to demonstrate accountability. If something isn’t working as expected, we want to know it and adjust. Thus far, however, the data have been overwhelmingly positive. Even so, we remain committed to full transparency – whether through publishing our outcomes on this website or collaborating in formal research studies. We understand that veterans, donors, and policymakers rightfully demand proof; providing that proof is a cornerstone of our mission. Our ultimate goal is to make eTMS an accepted, mainstream treatment covered by insurance and government programs, so that every veteran or first responder in need can access it. The first step toward that goal is solid data and honest reporting, which you will always get from Hero Brain Health.

The impact of eTMS is backed by strong data

FDA clearance for PTSD, meaningful symptom relief in published studies and state programs, and life-changing outcomes documented in both scientific literature and personal stories. Hero Brain Health stands by these findings and will continue to hold ourselves to the highest standards of clinical accountability.

If you are a healthcare professional or researcher interested in our data, or a policymaker looking to evaluate our program, please contact us. We are happy to share details and even arrange a demonstration of our treatment and data systems. Together, through transparency and results, we can advance the standard of care for our nation’s heroes.